Retention: Two Methods

New York University Medical Center is isolated on the edge of Manhattan's affluent Kip's Bay neighborhood, an area that includes only sparse pockets of subsidized lower- and middle-income housing. According to Kay Ryan, director of clinical trials development for the center, "Here, the patient population is not more than half minority, and here we have to do something to recruit minorities." "Something," in NYU's case, is recruiting patients for its cancer trials from Bellevue Hospital Center,

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

New York University Medical Center is isolated on the edge of Manhattan's affluent Kip's Bay neighborhood, an area that includes only sparse pockets of subsidized lower- and middle-income housing. According to Kay Ryan, director of clinical trials development for the center, "Here, the patient population is not more than half minority, and here we have to do something to recruit minorities."

"Something," in NYU's case, is recruiting patients for its cancer trials from Bellevue Hospital Center, the large municipal hospital next door that serves much of mid- and downtown Manhattan's minority and poor population, and from the Manhattan Veterans Administration Hospital several blocks away, for recruitment into the cancer center's many studies, says outreach coordinator Caron Bowen. She cites other problems they face: Some of the patients are homeless; others are barely meeting the rent. This creates what she calls "issues of compliance."

"We do try to find creative ways ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Myrna Watanabe

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution